Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
BPC-157 has never been tested in humans for GERD, acid reflux, or any other medical condition
The study by Honda et al., conducted in 2017, was an open-label, single-arm, multicentre pilot study that evaluated the therapeutic effect of oral glutathione administration (300 mg/day) in patients with NAFLD through the evolution of biochemical indices (ALT) and liver fat levels assessed by VCTE (79)
Glutathione helps protect your liver from becoming overloaded with toxins, ensuring that it can continue to do its vital job of detoxification
Lipid Metabolism & 3-AR Mechanism Heffernan et al., Endocrinology (2001) Heffernan and colleagues investigated the lipolytic effects of chronic AOD-9604 treatment using two complementary mouse models: diet-induced obese C57BL/6J mice and beta3 adrenergic receptor (3-AR) knockout mice
US$ 21.29
US$ 22.61
US$ 26.13
US$ 21.23
US$ 29.44
US$ 22.71
US$ 24.74
US$ 24.07
US$ 26.51
